Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Liquid Biopsy in Non-Small Cell Lung Cancer: Highlights and Challenges
Erika Rijavec, Simona Coco, Carlo Genova, et al.
Cancers (2019) Vol. 12, Iss. 1, pp. 17-17
Open Access | Times Cited: 105

Showing 1-25 of 105 citing articles:

Advancing to the era of cancer immunotherapy
Yun Wang, Min Wang, Hao‐Xiang Wu, et al.
Cancer Communications (2021) Vol. 41, Iss. 9, pp. 803-829
Open Access | Times Cited: 129
The Role of Liquid Biopsy in Early Diagnosis of Lung Cancer
Cláudia Freitas, Catarina Sousa, Francisco Machado, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 73
FLIM as a Promising Tool for Cancer Diagnosis and Treatment Monitoring
Yuzhen Ouyang, Yanping Liu, Zhiming M. Wang, et al.
Nano-Micro Letters (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 66
Single-cell microRNA sequencing method comparison and application to cell lines and circulating lung tumor cells
Sarah M. Hücker, Tobias Fehlmann, Christian Werno, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 64
Non-small cell lung carcinoma (NSCLC): Implications on molecular pathology and advances in early diagnostics and therapeutics
Hafiza Padinharayil, Jinsu Varghese, Mithun Chacko John, et al.
Genes & Diseases (2022) Vol. 10, Iss. 3, pp. 960-989
Open Access | Times Cited: 64
Early diagnosis of lung cancer: which is the optimal choice?
Jing Ning, Ge Tao, Minlin Jiang, et al.
Aging (2021) Vol. 13, Iss. 4, pp. 6214-6227
Open Access | Times Cited: 60
Antibody-drug conjugates for the treatment of lymphoma: clinical advances and latest progress
Yurou Chu, Xiangxiang Zhou, Xin Wang
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 59
The evolving role of liquid biopsy in lung cancer
Umberto Malapelle, Pasquale Pisapia, Francesco Pepe, et al.
Lung Cancer (2022) Vol. 172, pp. 53-64
Closed Access | Times Cited: 47
Cancer Stem Cell Derived Extracellular Vesicles with Self-Functionalized 3D Nanosensor for Real-Time Cancer Diagnosis: Eliminating the Roadblocks in Liquid Biopsy
Rupa Haldavnekar, Krishnan Venkatakrishnan, Bo Tan
ACS Nano (2022) Vol. 16, Iss. 8, pp. 12226-12243
Closed Access | Times Cited: 38
Precision Medicine for NSCLC in the Era of Immunotherapy: New Biomarkers to Select the Most Suitable Treatment or the Most Suitable Patient
Giovanni Rossi, Alessandro Russo, Marco Tagliamento, et al.
Cancers (2020) Vol. 12, Iss. 5, pp. 1125-1125
Open Access | Times Cited: 59
Blood-based liquid biopsy: Insights into early detection and clinical management of lung cancer
Cuiliu Liu, Xiaoqiang Xiang, Shuangqing Han, et al.
Cancer Letters (2021) Vol. 524, pp. 91-102
Closed Access | Times Cited: 49
Circulating Biomarkers of Response and Toxicity of Immunotherapy in Advanced Non-Small Cell Lung Cancer (NSCLC): A Comprehensive Review
Alice Indini, Erika Rijavec, Francesco Grossi
Cancers (2021) Vol. 13, Iss. 8, pp. 1794-1794
Open Access | Times Cited: 45
The Role of Circulating Biomarkers in Lung Cancer
Sayuri Herath, Habib Sadeghi Rad, Payar Radfar, et al.
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 33
A Classifier for Improving Early Lung Cancer Diagnosis Incorporating Artificial Intelligence and Liquid Biopsy
Maosong Ye, Lin Tong, Xiaoxuan Zheng, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 28
Towards Machine Learning-Aided Lung Cancer Clinical Routines: Approaches and Open Challenges
Francisco Silva, Tânia Pereira, Inês Neves, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 3, pp. 480-480
Open Access | Times Cited: 27
Roles of Tumor-Educated Platelets (TEPs) in the biology of Non-Small Cell Lung Cancer (NSCLC): A systematic review. “Re-discovering the neglected biosources of the liquid biopsy family”
Andrea Gottardo, Valerio Gristina, Alessandro Perez, et al.
The Journal of Liquid Biopsy (2024) Vol. 3, pp. 100136-100136
Open Access | Times Cited: 5
High-Throughput Microfluidic Extraction of Platelet-free Plasma for MicroRNA and Extracellular Vesicle Analysis
Sheng Yuan Leong, Wan Wei Lok, Kah Yee Goh, et al.
ACS Nano (2024) Vol. 18, Iss. 8, pp. 6623-6637
Closed Access | Times Cited: 5
Circulating biomarkers as predictors of response to immune checkpoint inhibitors in NSCLC: Are we on the right path?
Calogera Claudia Spagnolo, Francesco Pepe, Giuliana Ciappina, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 197, pp. 104332-104332
Open Access | Times Cited: 5
Unveiling the hidden role of tumor-educated platelets in cancer: a promising marker for early diagnosis and treatment
Du Wen, Jiahui Liu, Shipeng Zhu, et al.
ONCOLOGIE (2025)
Closed Access
Identification of tumor-educated platelet biomarkers of non-small-cell lung cancer
Meiling Sheng, Zhaohui Dong, Yanping Xie
OncoTargets and Therapy (2018) Vol. Volume 11, pp. 8143-8151
Open Access | Times Cited: 57
Validation of Lung EpiCheck, a novel methylation-based blood assay, for the detection of lung cancer in European and Chinese high-risk individuals
Mina Gaga, Joanna Chorostowska‐Wynimko, Ildikó Horváth, et al.
European Respiratory Journal (2020) Vol. 57, Iss. 1, pp. 2002682-2002682
Open Access | Times Cited: 39
Serum Exosomes and Their miRNA Load—A Potential Biomarker of Lung Cancer
Mateusz Smolarz, Piotr Widłak
Cancers (2021) Vol. 13, Iss. 6, pp. 1373-1373
Open Access | Times Cited: 38
Clinical Potential of Circulating Cell-Free DNA (cfDNA) for Longitudinally Monitoring Clinical Outcomes in the First-Line Setting of Non-Small-Cell Lung Cancer (NSCLC): A Real-World Prospective Study
Valerio Gristina, Nadia Barraco, Maria La Mantia, et al.
Cancers (2022) Vol. 14, Iss. 23, pp. 6013-6013
Open Access | Times Cited: 23
Genomic Landscape of Non-Small Cell Lung Cancer (NSCLC) in East Asia Using Circulating Tumor DNA (ctDNA) in Clinical Practice
Byoung Chul Cho, Herbert H. Loong, Chun‐Ming Tsai, et al.
Current Oncology (2022) Vol. 29, Iss. 3, pp. 2154-2164
Open Access | Times Cited: 22
The diagnostic and prognostic value of exosomal microRNAs in lung cancer: a systematic review
Bingbing Yang, Xiaoqi Xin, Xiaoqing Cao, et al.
Clinical & Translational Oncology (2024) Vol. 26, Iss. 8, pp. 1921-1933
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top